Over the past six weeks, Veritas IRB has been assisting researchers and sponsors navigate through the challenges that the COVID-19 pandemic presents to their research. Over the coming days, we will share different issues that were presented to the IRB. This blog posting will address issues pertaining to obtaining and documenting free and informed consent. […]
Category Archives: Informed Consent
In recognition of World Asthma Day, we wish to underline the importance of pursuing clinical research in order to improve the quality of life for the 300 million people affected by this disease. It is also important to remember those, like Ellen Roche, who participated in such clinical research. Ellen Roche was an employee at […]
It is refreshing to see policy changes influenced by the evolution of science as opposed to crisis. The increased engagement of research participants in research coupled with increasing complexities in the research landscape have catalyzed revisions to the Common Rule. Inspired by the Belmont Report, the Common Rule was developed to ensure that research involving […]
November has no doubt been a month of interesting discussions and debates surrounding research and bioethics, as showcased recently at the 2015 PRIM&R Conference in Boston. (Editor’s note: for an in-depth look at our coverage from PRIM&R 2015, we welcome you to view our blog posts on PRIM&R Pre-Conference Highlights: From IRB 101 to Biobanking, […]
We all know how challenging drafting an effective informed consent form for research can be. As a researcher, you have the dual duty to disclose all the information considered to be legally and ethically necessary to make an informed decision in a manner that will be understandable to the prospective research participant. Many efforts have […]
When do you think this process begins? Take a moment to think about it before reading on… Does the informed consent process begin with the informed consent discussion? It may surprise you, but the “FDA considers direct advertising for study subjects to be the start of the informed consent and subject selection process”. This means […]
- 1
- 2